NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients | NIH: National Institute of Allergy and Infectious Diseases

NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients | NIH: National Institute of Allergy and Infectious Diseases

Thursday, February 14, 2018 NIH Clinical Trial to Track Outcomes of Liver Transplantation From HIV-Positive Donors to HIV-Positive Recipients On National Donor Day, NIAID announces the launch of the first large-scale clinical trial to study liver transplantations between people with HIV. The NIAID-supported HOPE in Action Multicenter Liver Study will determine the safety of this practice by evaluating liver recipients for potential transplant-related and HIV-related complications following surgery.